{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:47:16Z","timestamp":1791805636835,"version":"4.3.4"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T00:00:00Z","timestamp":1730505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T00:00:00Z","timestamp":1730505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-024-00823-x","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T15:02:15Z","timestamp":1730559735000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Biomarkers for cognitive impairment in alpha-synucleinopathies: an overview of systematic reviews and meta-analyses"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3717-7697","authenticated-orcid":false,"given":"Elisa","family":"Mantovani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Dinoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Zucchella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mariotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Tinazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1561-2187","authenticated-orcid":false,"given":"Stefano","family":"Tamburin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,2]]},"reference":[{"key":"823_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nm.4269","volume":"23","author":"YC Wong","year":"2017","unstructured":"Wong, Y. C. & Krainc, D. \u03b1-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies. Nat. Med 23, 1\u201313 (2017).","journal-title":"Nat. Med"},{"key":"823_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-021-00501-z","volume":"16","author":"S Koga","year":"2021","unstructured":"Koga, S., Sekiya, H., Kondru, N., Ross, O. A. & Dickson, D. W. Neuropathology and molecular diagnosis of Synucleinopathies. Mol. Neurodegener. 16, 83 (2021).","journal-title":"Mol. Neurodegener."},{"key":"823_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-015-1485-1","volume":"131","author":"T Uchihara","year":"2016","unstructured":"Uchihara, T. & Giasson, B. I. Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol. 131, 49\u201373 (2016).","journal-title":"Acta Neuropathol."},{"key":"823_CR4","doi-asserted-by":"publisher","first-page":"a028035","DOI":"10.1101\/cshperspect.a028035","volume":"9","author":"BN Dugger","year":"2017","unstructured":"Dugger, B. N. & Dickson, D. W. Pathology of Neurodegenerative Diseases. Cold Spring Harb. Perspect. Biol. 9, a028035 (2017).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"823_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/brain\/aww230","volume":"140","author":"M Goedert","year":"2017","unstructured":"Goedert, M., Masuda-Suzukake, M. & Falcon, B. Like prions: the propagation of aggregated tau and \u03b1-synuclein in neurodegeneration. Brain 140, 266\u2013278 (2017).","journal-title":"Brain"},{"key":"823_CR6","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1001\/jamaneurol.2013.114","volume":"70","author":"R Savica","year":"2013","unstructured":"Savica, R., Grossardt, B. R., Bower, J. H., Ahlskog, J. E. & Rocca, W. A. Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism. JAMA Neurol. 70, 859\u2013866 (2013).","journal-title":"JAMA Neurol."},{"key":"823_CR7","doi-asserted-by":"publisher","unstructured":"Weintraub, D. What\u2019s in a Name? The Time Has Come to Unify Parkinson\u2019s Disease and Dementia with Lewy Bodies. Mov Disord https:\/\/doi.org\/10.1002\/mds.29590 (2023).","DOI":"10.1002\/mds.29590"},{"key":"823_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-022-00382-6","volume":"8","author":"W Poewe","year":"2022","unstructured":"Poewe, W. et al. Multiple system atrophy. Nat. Rev. Dis. Prim. 8, 56 (2022).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"823_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","volume":"23","author":"GU H\u00f6glinger","year":"2024","unstructured":"H\u00f6glinger, G. U. et al. A biological classification of Parkinson\u2019s disease: the SynNeurGe research diagnostic criteria. Lancet Neurol. 23, 191\u2013204 (2024).","journal-title":"Lancet Neurol."},{"key":"823_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","volume":"23","author":"T Simuni","year":"2024","unstructured":"Simuni, T. et al. A biological definition of neuronal \u03b1-synuclein disease: towards an integrated staging system for research. Lancet Neurol. 23, 178\u2013190 (2024).","journal-title":"Lancet Neurol."},{"key":"823_CR11","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/bs.irn.2017.05.023","volume":"133","author":"P Barone","year":"2017","unstructured":"Barone, P., Erro, R. & Picillo, M. Quality of Life and Nonmotor Symptoms in Parkinson\u2019s Disease. Int Rev. Neurobiol. 133, 499\u2013516 (2017).","journal-title":"Int Rev. Neurobiol."},{"key":"823_CR12","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/bs.irn.2017.06.001","volume":"134","author":"KP Bhatia","year":"2017","unstructured":"Bhatia, K. P. & Stamelou, M. Nonmotor Features in Atypical Parkinsonism. Int Rev. Neurobiol. 134, 1285\u20131301 (2017).","journal-title":"Int Rev. Neurobiol."},{"key":"823_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland, D. et al. Parkinson disease-associated cognitive impairment. Nat. Rev. Dis. Prim. 7, 47 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"823_CR14","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/mds.25880","volume":"29","author":"I Stankovic","year":"2014","unstructured":"Stankovic, I. et al. Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group. Mov. Disord. 29, 857\u2013867 (2014).","journal-title":"Mov. Disord."},{"key":"823_CR15","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.3233\/JPD-223444","volume":"12","author":"Y Cui","year":"2022","unstructured":"Cui, Y., Cao, S., Li, F. & Feng, T. Prevalence and Clinical Characteristics of Dementia and Cognitive Impairment in Multiple System Atrophy: A Systematic Review and Meta-Analysis. J. Parkinsons Dis. 12, 2383\u20132395 (2022).","journal-title":"J. Parkinsons Dis."},{"key":"823_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/14737175.2023.2173576","volume":"23","author":"E Mantovani","year":"2023","unstructured":"Mantovani, E., Zucchella, C., Argyriou, A. A. & Tamburin, S. Treatment for cognitive and neuropsychiatric non-motor symptoms in Parkinson\u2019s disease: current evidence and future perspectives. Expert Rev. Neurother. 23, 25\u201343 (2023).","journal-title":"Expert Rev. Neurother."},{"key":"823_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00702-019-02129-2","volume":"127","author":"A Martini","year":"2020","unstructured":"Martini, A. et al. Differences in cognitive profiles between Lewy body and Parkinson\u2019s disease dementia. J. Neural Transm. (Vienna) 127, 323\u2013330 (2020).","journal-title":"J. Neural Transm. (Vienna)"},{"key":"823_CR18","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s11065-022-09551-6","volume":"33","author":"S Raimo","year":"2023","unstructured":"Raimo, S. et al. The Cognitive Profile of Atypical Parkinsonism: A Meta-Analysis. Neuropsychol. Rev. 33, 514\u2013543 (2023).","journal-title":"Neuropsychol. Rev."},{"key":"823_CR19","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1001\/jamaneurol.2020.1741","volume":"77","author":"S Karanth","year":"2020","unstructured":"Karanth, S. et al. Prevalence and Clinical Phenotype of Quadruple Misfolded Proteins in Older Adults. JAMA Neurol. 77, 1299\u20131307 (2020).","journal-title":"JAMA Neurol."},{"key":"823_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/jnc.14698","volume":"150","author":"L Walker","year":"2019","unstructured":"Walker, L., Stefanis, L. & Attems, J. Clinical and neuropathological differences between Parkinson\u2019s disease, Parkinson\u2019s disease dementia and dementia with Lewy bodies - current issues and future directions. J. Neurochem 150, 467\u2013474 (2019).","journal-title":"J. Neurochem"},{"key":"823_CR21","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1093\/brain\/awv104","volume":"138","author":"J Gratwicke","year":"2015","unstructured":"Gratwicke, J., Jahanshahi, M. & Foltynie, T. Parkinson\u2019s disease dementia: a neural networks perspective. Brain 138, 1454\u20131476 (2015).","journal-title":"Brain"},{"key":"823_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/bs.pbr.2022.01.013","volume":"269","author":"I Frouni","year":"2022","unstructured":"Frouni, I., Kwan, C., Belliveau, S. & Huot, P. Cognition and serotonin in Parkinson\u2019s disease. Prog. Brain Res 269, 373\u2013403 (2022).","journal-title":"Prog. Brain Res"},{"key":"823_CR23","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/mds.28913","volume":"37","author":"S van der Zee","year":"2022","unstructured":"van der Zee, S. et al. Altered Cholinergic Innervation in De Novo Parkinson\u2019s Disease with and Without Cognitive Impairment. Mov. Disord. 37, 713\u2013723 (2022).","journal-title":"Mov. Disord."},{"key":"823_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","volume":"27","author":"I Litvan","year":"2012","unstructured":"Litvan, I. et al. Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society Task Force guidelines. Mov. Disord. 27, 349\u2013356 (2012).","journal-title":"Mov. Disord."},{"key":"823_CR25","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1002\/alz.13105","volume":"19","author":"PC Donaghy","year":"2023","unstructured":"Donaghy, P. C. et al. Research diagnostic criteria for mild cognitive impairment with Lewy bodies: A systematic review and meta-analysis. Alzheimers Dement 19, 3186\u20133202 (2023).","journal-title":"Alzheimers Dement"},{"key":"823_CR26","doi-asserted-by":"publisher","first-page":"9.23.1","DOI":"10.1002\/cpph.19","volume":"76","author":"JK Aronson","year":"2017","unstructured":"Aronson, J. K. & Ferner, R. E. Biomarkers-A General Review. Curr. Protoc. Pharm. 76, 9.23.1\u20139.23.17 (2017).","journal-title":"Curr. Protoc. Pharm."},{"key":"823_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41746-019-0090-4","volume":"2","author":"A Coravos","year":"2019","unstructured":"Coravos, A., Khozin, S. & Mandl, K. D. Developing and adopting safe and effective digital biomarkers to improve patient outcomes. NPJ Digit. Med. 2, 14 (2019).","journal-title":"NPJ Digit. Med"},{"key":"823_CR28","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/mds.26662","volume":"31","author":"M Delgado\u2010Alvarado","year":"2016","unstructured":"Delgado\u2010Alvarado, M., Gago, B., Navalpotro\u2010Gomez, I., Jim\u00e9nez\u2010Urbieta, H. & Rodriguez\u2010Oroz, M. C. Biomarkers for dementia and mild cognitive impairment in Parkinson\u2019s disease. Mov. Disord. 31, 861\u2013881 (2016).","journal-title":"Mov. Disord."},{"key":"823_CR29","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/j.parkreldis.2017.07.023","volume":"46","author":"LV Kalia","year":"2018","unstructured":"Kalia, L. V. Biomarkers for cognitive dysfunction in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 46, S19\u2013S23 (2018).","journal-title":"Parkinsonism Relat. Disord."},{"key":"823_CR30","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1007\/s00415-020-09863-8","volume":"268","author":"E Sarasso","year":"2021","unstructured":"Sarasso, E., Agosta, F., Piramide, N. & Filippi, M. Progression of grey and white matter brain damage in Parkinson\u2019s disease: a critical review of structural MRI literature. J. Neurol. 268, 3144\u20133179 (2021).","journal-title":"J. Neurol."},{"key":"823_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.parkreldis.2019.10.002","volume":"73","author":"SG Ryman","year":"2020","unstructured":"Ryman, S. G. & Poston, K. L. MRI biomarkers of motor and non-motor symptoms in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 73, 85\u201393 (2020).","journal-title":"Parkinsonism Relat. Disord."},{"key":"823_CR32","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1002\/hbm.24562","volume":"40","author":"LI Boon","year":"2019","unstructured":"Boon, L. I. et al. A systematic review of MEG\u2010based studies in Parkinson\u2019s disease: The motor system and beyond. Hum. Brain Mapp. 40, 2827\u20132848 (2019).","journal-title":"Hum. Brain Mapp."},{"key":"823_CR33","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1212\/WNL.0000000000006473","volume":"91","author":"VJ Geraedts","year":"2018","unstructured":"Geraedts, V. J. et al. Clinical correlates of quantitative EEG in Parkinson disease: A systematic review. Neurology 91, 871\u2013883 (2018).","journal-title":"Neurology"},{"key":"823_CR34","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1002\/jnr.24863","volume":"99","author":"D Pourzinal","year":"2021","unstructured":"Pourzinal, D. et al. Hippocampal correlates of episodic memory in Parkinson\u2019s disease: A systematic review of magnetic resonance imaging studies. J. Neurosci. Res. 99, 2097\u20132116 (2021).","journal-title":"J. Neurosci. Res."},{"key":"823_CR35","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.parkreldis.2022.02.006","volume":"95","author":"Q Devignes","year":"2022","unstructured":"Devignes, Q., Lopes, R. & Dujardin, K. Neuroimaging outcomes associated with mild cognitive impairment subtypes in Parkinson\u2019s disease: A systematic review. Parkinsonism Relat. Disord. 95, 122\u2013137 (2022).","journal-title":"Parkinsonism Relat. Disord."},{"key":"823_CR36","doi-asserted-by":"publisher","first-page":"102197","DOI":"10.1016\/j.arr.2024.102197","volume":"94","author":"M Visser","year":"2024","unstructured":"Visser, M., O\u2019Brien, J. T. & Mak, E. In vivo imaging of synaptic density in neurodegenerative disorders with positron emission tomography: A systematic review. Ageing Res. Rev. 94, 102197 (2024).","journal-title":"Ageing Res. Rev."},{"key":"823_CR37","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/mds.26191","volume":"30","author":"M Petrou","year":"2015","unstructured":"Petrou, M. et al. Amyloid deposition in Parkinson\u2019s disease and cognitive impairment: A systematic review. Mov. Disord. 30, 928\u2013935 (2015).","journal-title":"Mov. Disord."},{"key":"823_CR38","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s11682-018-9922-0","volume":"13","author":"AS Mihaescu","year":"2019","unstructured":"Mihaescu, A. S. et al. Brain degeneration in Parkinson\u2019s disease patients with cognitive decline: a coordinate-based meta-analysis. Brain Imaging Behav. 13, 1021\u20131034 (2019).","journal-title":"Brain Imaging Behav."},{"key":"823_CR39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.parkreldis.2018.12.016","volume":"62","author":"AF Wolters","year":"2019","unstructured":"Wolters, A. F. et al. Resting-state fMRI in Parkinson\u2019s disease patients with cognitive impairment: A meta-analysis. Parkinsonism Relat. Disord. 62, 16\u201327 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"823_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2019.111973","volume":"371","author":"D Zheng","year":"2019","unstructured":"Zheng, D. et al. Regional gray matter reductions associated with mild cognitive impairment in Parkinson\u2019s disease: A meta-analysis of voxel-based morphometry studies. Behavioural Brain Res. 371, 111973 (2019).","journal-title":"Behavioural Brain Res."},{"key":"823_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2020.146847","volume":"1740","author":"H He","year":"2020","unstructured":"He, H. et al. Progressive brain changes in Parkinson\u2019s disease: A meta-analysis of structural magnetic resonance imaging studies. Brain Res. 1740, 146847 (2020).","journal-title":"Brain Res."},{"key":"823_CR42","doi-asserted-by":"publisher","first-page":"133679","DOI":"10.1016\/j.neulet.2018.06.048","volume":"719","author":"JF Martin-Rodriguez","year":"2020","unstructured":"Martin-Rodriguez, J. F. & Mir, P. Short-afferent inhibition and cognitive impairment in Parkinson\u2019s disease: A quantitative review and challenges. Neurosci. Lett. 719, 133679 (2020).","journal-title":"Neurosci. Lett."},{"key":"823_CR43","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x20209275","volume":"53","author":"B Qin","year":"2020","unstructured":"Qin, B. et al. Voxel-wise meta-analysis of structural changes in gray matter of Parkinson\u2019s disease patients with mild cognitive impairment. Braz. J. Med Biol. Res 53, e9275 (2020).","journal-title":"Braz. J. Med Biol. Res"},{"key":"823_CR44","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1007\/s00415-016-8122-3","volume":"263","author":"Y Xu","year":"2016","unstructured":"Xu, Y., Yang, J., Hu, X. & Shang, H. Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson\u2019s disease. J. Neurol. 263, 1178\u20131187 (2016).","journal-title":"J. Neurol."},{"key":"823_CR45","doi-asserted-by":"publisher","first-page":"6719","DOI":"10.1007\/s10072-022-06348-6","volume":"43","author":"H Xu","year":"2022","unstructured":"Xu, H. et al. N200 and P300 component changes in Parkinson\u2019s disease: a meta-analysis. Neurol. Sci. 43, 6719\u20136730 (2022).","journal-title":"Neurol. Sci."},{"key":"823_CR46","doi-asserted-by":"publisher","first-page":"1145939","DOI":"10.3389\/fneur.2023.1145939","volume":"14","author":"J Zhang","year":"2023","unstructured":"Zhang, J., Jin, J., Su, D., Feng, T. & Zhao, H. Tau-PET imaging in Parkinson\u2019s disease: a systematic review and meta-analysis. Front. Neurol. 14, 1145939 (2023).","journal-title":"Front. Neurol."},{"key":"823_CR47","doi-asserted-by":"publisher","first-page":"105451","DOI":"10.1016\/j.neubiorev.2023.105451","volume":"155","author":"Y Mimura","year":"2023","unstructured":"Mimura, Y. et al. Transcranial magnetic stimulation neurophysiology in patients with non-Alzheimer\u2019s neurodegenerative diseases: A systematic review and meta-analysis. Neurosci. Biobehav. Rev. 155, 105451 (2023).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"823_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/B978-0-12-394816-8.00002-7","volume":"64","author":"AD Cohen","year":"2012","unstructured":"Cohen, A. D. et al. Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta. Adv. Pharm. 64, 27\u201381 (2012).","journal-title":"Adv. Pharm."},{"key":"823_CR49","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/ane.12590","volume":"135","author":"AD Andersen","year":"2017","unstructured":"Andersen, A. D., Binzer, M., Stenager, E. & Gramsbergen, J. B. Cerebrospinal fluid biomarkers for Parkinson\u2019s disease - a systematic review. Acta Neurol. Scand. 135, 34\u201356 (2017).","journal-title":"Acta Neurol. Scand."},{"key":"823_CR50","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1007\/s10072-017-3088-1","volume":"38","author":"X Hu","year":"2017","unstructured":"Hu, X., Yang, Y. & Gong, D. Changes of cerebrospinal fluid A\u03b242, t-tau, and p-tau in Parkinson\u2019s disease patients with cognitive impairment relative to those with normal cognition: a meta-analysis. Neurol. Sci. 38, 1953\u20131961 (2017).","journal-title":"Neurol. Sci."},{"key":"823_CR51","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neulet.2016.11.007","volume":"636","author":"Y Xie","year":"2017","unstructured":"Xie, Y., Feng, H., Peng, S., Xiao, J. & Zhang, J. Association of plasma homocysteine, vitamin B12 and folate levels with cognitive function in Parkinson\u2019s disease: A meta-analysis. Neurosci. Lett. 636, 190\u2013195 (2017).","journal-title":"Neurosci. Lett."},{"key":"823_CR52","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x20198443","volume":"52","author":"Q Wang","year":"2019","unstructured":"Wang, Q. et al. Association between BDNF G196A (Val66Met) polymorphism and cognitive impairment in patients with Parkinson\u2019s disease: a meta-analysis. Braz. J. Med Biol. Res 52, e8443 (2019).","journal-title":"Braz. J. Med Biol. Res"},{"key":"823_CR53","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1007\/s10072-019-03907-2","volume":"40","author":"Y Yin","year":"2019","unstructured":"Yin, Y., Su, X., Pan, L. & Li, C. BDNF Val66Met polymorphism and cognitive impairment in Parkinson\u2019s disease\u2014a meta-analysis. Neurol. Sci. 40, 1901\u20131907 (2019).","journal-title":"Neurol. Sci."},{"key":"823_CR54","doi-asserted-by":"publisher","first-page":"349","DOI":"10.31083\/j.jin2002034","volume":"20","author":"C-G Yang","year":"2021","unstructured":"Yang, C.-G., Cai, S.-M., Liu, C.-Y. & Chen, C. On the correlation between serum Cystatin C and Parkinson\u2019s disease in the Chinese population: a promising biomarker? J. Integr. Neurosci. 20, 349 (2021).","journal-title":"J. Integr. Neurosci."},{"key":"823_CR55","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.parkreldis.2022.06.004","volume":"101","author":"YY Wong","year":"2022","unstructured":"Wong, Y. Y. et al. Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysis. Parkinsonism Relat. Disord. 101, 119\u2013128 (2022).","journal-title":"Parkinsonism Relat. Disord."},{"key":"823_CR56","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1007\/s00415-020-09757-9","volume":"268","author":"Y Guo","year":"2021","unstructured":"Guo, Y. et al. Predictors of cognitive impairment in Parkinson\u2019s disease: a systematic review and meta-analysis of prospective cohort studies. J. Neurol. 268, 2713\u20132722 (2021).","journal-title":"J. Neurol."},{"key":"823_CR57","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1212\/01.WNL.0000149510.41793.50","volume":"64","author":"A Nagano-Saito","year":"2005","unstructured":"Nagano-Saito, A. et al. Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 64, 224\u2013229 (2005).","journal-title":"Neurology"},{"key":"823_CR58","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1002\/mds.23868","volume":"26","author":"A Kudlicka","year":"2011","unstructured":"Kudlicka, A., Clare, L. & Hindle, J. V. Executive functions in Parkinson\u2019s disease: systematic review and meta-analysis. Mov. Disord. 26, 2305\u20132315 (2011).","journal-title":"Mov. Disord."},{"key":"823_CR59","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s10548-018-0675-2","volume":"32","author":"J Kunst","year":"2019","unstructured":"Kunst, J. et al. Patterns of Grey Matter Atrophy at Different Stages of Parkinson\u2019s and Alzheimer\u2019s Diseases and Relation to Cognition. Brain Topogr. 32, 142\u2013160 (2019).","journal-title":"Brain Topogr."},{"key":"823_CR60","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/jnnp-2018-319592","volume":"90","author":"A Low","year":"2019","unstructured":"Low, A., Foo, H., Yong, T. T., Tan, L. C. S. & Kandiah, N. Hippocampal subfield atrophy of CA1 and subicular structures predict progression to dementia in idiopathic Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 90, 681\u2013687 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"823_CR61","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11065-021-09502-7","volume":"32","author":"ER Wallace","year":"2022","unstructured":"Wallace, E. R., Segerstrom, S. C., van Horne, C. G., Schmitt, F. A. & Koehl, L. M. Meta-Analysis of Cognition in Parkinson\u2019s Disease Mild Cognitive Impairment and Dementia Progression. Neuropsychol. Rev. 32, 149\u2013160 (2022).","journal-title":"Neuropsychol. Rev."},{"key":"823_CR62","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/brain\/awt337","volume":"137","author":"L Christopher","year":"2014","unstructured":"Christopher, L. et al. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson\u2019s disease with mild cognitive impairment. Brain 137, 565\u2013575 (2014).","journal-title":"Brain"},{"key":"823_CR63","doi-asserted-by":"publisher","first-page":"15918","DOI":"10.1073\/pnas.1205102109","volume":"109","author":"MWC Rousseaux","year":"2012","unstructured":"Rousseaux, M. W. C. et al. Progressive dopaminergic cell loss with unilateral-to-bilateral progression in a genetic model of Parkinson disease. Proc. Natl Acad. Sci. USA 109, 15918\u201315923 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"823_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.573","volume":"6","author":"DO Claassen","year":"2016","unstructured":"Claassen, D. O. et al. Cortical asymmetry in Parkinson\u2019s disease: early susceptibility of the left hemisphere. Brain Behav. 6, e00573 (2016).","journal-title":"Brain Behav."},{"key":"823_CR65","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bbr.2015.01.021","volume":"283","author":"DJ Serrien","year":"2015","unstructured":"Serrien, D. J. & Sovij\u00e4rvi-Spap\u00e9, M. M. Hemispheric asymmetries and the control of motor sequences. Behav. Brain Res 283, 30\u201336 (2015).","journal-title":"Behav. Brain Res"},{"key":"823_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2020.102374","volume":"28","author":"M Filippi","year":"2020","unstructured":"Filippi, M. et al. Progressive brain atrophy and clinical evolution in Parkinson\u2019s disease. Neuroimage Clin. 28, 102374 (2020).","journal-title":"Neuroimage Clin."},{"key":"823_CR67","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.tins.2017.02.002","volume":"40","author":"H Namkung","year":"2017","unstructured":"Namkung, H., Kim, S.-H. & Sawa, A. The Insula: An Underestimated Brain Area in Clinical Neuroscience, Psychiatry, and Neurology. Trends Neurosci. 40, 200\u2013207 (2017).","journal-title":"Trends Neurosci."},{"key":"823_CR68","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41583-021-00474-4","volume":"22","author":"J Smallwood","year":"2021","unstructured":"Smallwood, J. et al. The default mode network in cognition: a topographical perspective. Nat. Rev. Neurosci. 22, 503\u2013513 (2021).","journal-title":"Nat. Rev. Neurosci."},{"key":"823_CR69","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.cortex.2017.03.016","volume":"92","author":"M Tahmasian","year":"2017","unstructured":"Tahmasian, M. et al. Resting-state functional reorganization in Parkinson\u2019s disease: An activation likelihood estimation meta-analysis. Cortex 92, 119\u2013138 (2017).","journal-title":"Cortex"},{"key":"823_CR70","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/nrneurol.2013.224","volume":"9","author":"A Conte","year":"2013","unstructured":"Conte, A., Khan, N., Defazio, G., Rothwell, J. C. & Berardelli, A. Pathophysiology of somatosensory abnormalities in Parkinson disease. Nat. Rev. Neurol. 9, 687\u2013697 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"823_CR71","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1212\/WNL.0b013e31826e2696","volume":"79","author":"MM Mielke","year":"2012","unstructured":"Mielke, M. M. et al. Indicators of amyloid burden in a population-based study of cognitively normal elderly. Neurology 79, 1570\u20131577 (2012).","journal-title":"Neurology"},{"key":"823_CR72","doi-asserted-by":"publisher","first-page":"e1608","DOI":"10.1212\/WNL.0000000000011612","volume":"96","author":"S Toppala","year":"2021","unstructured":"Toppala, S. et al. Association of Early \u03b2-Amyloid Accumulation and Neuroinflammation Measured With [11C]PBR28 in Elderly Individuals Without Dementia. Neurology 96, e1608\u2013e1619 (2021).","journal-title":"Neurology"},{"key":"823_CR73","doi-asserted-by":"publisher","unstructured":"Jack, C. R. et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimer\u2019s & Dementia alz. 13859 https:\/\/doi.org\/10.1002\/alz.13859 (2024).","DOI":"10.1002\/alz.13859"},{"key":"823_CR74","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/alz.13355","volume":"20","author":"C Boccalini","year":"2024","unstructured":"Boccalini, C. et al. The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline. Alzheimer\u2019s Dement. 20, 221\u2013233 (2024).","journal-title":"Alzheimer\u2019s Dement."},{"key":"823_CR75","doi-asserted-by":"publisher","first-page":"101878","DOI":"10.1016\/j.pneurobio.2020.101878","volume":"194","author":"Z Jafari","year":"2020","unstructured":"Jafari, Z., Kolb, B. E. & Mohajerani, M. H. Neural oscillations and brain stimulation in Alzheimer\u2019s disease. Prog. Neurobiol. 194, 101878 (2020).","journal-title":"Prog. Neurobiol."},{"key":"823_CR76","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1093\/brain\/awab372","volume":"145","author":"J Schumacher","year":"2022","unstructured":"Schumacher, J. et al. Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer\u2019s disease. Brain 145, 1773\u20131784 (2022).","journal-title":"Brain"},{"key":"823_CR77","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1001\/jamaneurol.2014.2757","volume":"72","author":"NI Bohnen","year":"2015","unstructured":"Bohnen, N. I. et al. Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects. JAMA Neurol. 72, 194\u2013200 (2015).","journal-title":"JAMA Neurol."},{"key":"823_CR78","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000341998","volume":"11","author":"AA Kehagia","year":"2013","unstructured":"Kehagia, A. A., Barker, R. A. & Robbins, T. W. Cognitive impairment in Parkinson\u2019s disease: the dual syndrome hypothesis. Neurodegener. Dis. 11, 79\u201392 (2013).","journal-title":"Neurodegener. Dis."},{"key":"823_CR79","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1212\/WNL.0b013e3182919029","volume":"80","author":"Z Ni","year":"2013","unstructured":"Ni, Z., Bahl, N., Gunraj, C. A., Mazzella, F. & Chen, R. Increased motor cortical facilitation and decreased inhibition in Parkinson disease. Neurology 80, 1746\u20131753 (2013).","journal-title":"Neurology"},{"key":"823_CR80","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1126\/science.887923","volume":"197","author":"M Kutas","year":"1977","unstructured":"Kutas, M., McCarthy, G. & Donchin, E. Augmenting mental chronometry: the P300 as a measure of stimulus evaluation time. Science 197, 792\u2013795 (1977).","journal-title":"Science"},{"key":"823_CR81","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000017212","volume":"11","author":"H Tanaka","year":"2000","unstructured":"Tanaka, H. et al. Event-related potential and EEG measures in Parkinson\u2019s disease without and with dementia. Dement Geriatr. Cogn. Disord. 11, 39\u201345 (2000).","journal-title":"Dement Geriatr. Cogn. Disord."},{"key":"823_CR82","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","volume":"13","author":"D Aarsland","year":"2017","unstructured":"Aarsland, D. et al. Cognitive decline in Parkinson disease. Nat. Rev. Neurol. 13, 217\u2013231 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"823_CR83","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJMoa011613","volume":"346","author":"S Seshadri","year":"2002","unstructured":"Seshadri, S. et al. Plasma homocysteine as a risk factor for dementia and Alzheimer\u2019s disease. N. Engl. J. Med 346, 476\u2013483 (2002).","journal-title":"N. Engl. J. Med"},{"key":"823_CR84","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3233\/JAD-171042","volume":"62","author":"AD Smith","year":"2018","unstructured":"Smith, A. D. et al. Homocysteine and Dementia: An International Consensus Statement. J. Alzheimers Dis. 62, 561\u2013570 (2018).","journal-title":"J. Alzheimers Dis."},{"key":"823_CR85","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1007\/s00702-023-02684-9","volume":"130","author":"O Phokaewvarangkul","year":"2023","unstructured":"Phokaewvarangkul, O. et al. Homocysteine, vitamin B metabolites, dopamine-substituting compounds, and symptomatology in Parkinson\u2019s disease: clinical and therapeutic considerations. J. Neural Transm. (Vienna) 130, 1451\u20131462 (2023).","journal-title":"J. Neural Transm. (Vienna)"},{"key":"823_CR86","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000523982","volume":"21","author":"A Imarisio","year":"2021","unstructured":"Imarisio, A. et al. Plasma Cystatin C Correlates with Plasma NfL Levels and Predicts Disease Progression in Parkinson\u2019s Disease. Neurodegener. Dis. 21, 109\u2013116 (2021).","journal-title":"Neurodegener. Dis."},{"key":"823_CR87","first-page":"1234","volume":"90","author":"C Smith","year":"2019","unstructured":"Smith, C. et al. Neuropathology of dementia in patients with Parkinson\u2019s disease: a systematic review of autopsy studies. J. Neurol. Neurosurg. Psychiatry 90, 1234\u20131243 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"823_CR88","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.brainres.2010.12.048","volume":"1375","author":"R Freunberger","year":"2011","unstructured":"Freunberger, R., Werkle-Bergner, M., Griesmayr, B., Lindenberger, U. & Klimesch, W. Brain oscillatory correlates of working memory constraints. Brain Res 1375, 93\u2013102 (2011).","journal-title":"Brain Res"},{"key":"823_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10146-y","volume":"7","author":"DH Hepp","year":"2017","unstructured":"Hepp, D. H. et al. Damaged fiber tracts of the nucleus basalis of Meynert in Parkinson\u2019s disease patients with visual hallucinations. Sci. Rep. 7, 10112 (2017).","journal-title":"Sci. Rep."},{"key":"823_CR90","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00702-019-01996-z","volume":"126","author":"MP Cecchini","year":"2019","unstructured":"Cecchini, M. P. et al. Olfaction and taste in Parkinson\u2019s disease: the association with mild cognitive impairment and the single cognitive domain dysfunction. J. Neural Transm. (Vienna) 126, 585\u2013595 (2019).","journal-title":"J. Neural Transm. (Vienna)"},{"key":"823_CR91","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","volume":"27","author":"O Hansson","year":"2021","unstructured":"Hansson, O. Biomarkers for neurodegenerative diseases. Nat. Med 27, 954\u2013963 (2021).","journal-title":"Nat. Med"},{"key":"823_CR92","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41531-022-00384-x","volume":"8","author":"L Batzu","year":"2022","unstructured":"Batzu, L. et al. Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson\u2019s disease. NPJ Parkinsons Dis. 8, 154 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"823_CR93","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.parkreldis.2022.05.020","volume":"105","author":"J Pagonabarraga","year":"2022","unstructured":"Pagonabarraga, J. et al. Dissociable contribution of plasma NfL and p-tau181 to cognitive impairment in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 105, 132\u2013138 (2022).","journal-title":"Parkinsonism Relat. Disord."},{"key":"823_CR94","doi-asserted-by":"publisher","unstructured":"Lyall, D. M. et al. Artificial intelligence for dementia-Applied models and digital health. Alzheimers Dement https:\/\/doi.org\/10.1002\/alz.13391 (2023).","DOI":"10.1002\/alz.13391"},{"key":"823_CR95","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jamaneurol.2013.6233","volume":"71","author":"MA Thenganatt","year":"2014","unstructured":"Thenganatt, M. A. & Jankovic, J. Parkinson disease subtypes. JAMA Neurol. 71, 499\u2013504 (2014).","journal-title":"JAMA Neurol."},{"key":"823_CR96","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.parkreldis.2015.09.027","volume":"22","author":"A Sauerbier","year":"2016","unstructured":"Sauerbier, A., Jenner, P., Todorova, A. & Chaudhuri, K. R. Non motor subtypes and Parkinson\u2019s disease. Parkinsonism Relat. Disord. 22, S41\u2013S46 (2016). Suppl 1.","journal-title":"Parkinsonism Relat. Disord."},{"key":"823_CR97","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41582-023-00802-5","volume":"19","author":"K Ray Chaudhuri","year":"2023","unstructured":"Ray Chaudhuri, K., Leta, V., Bannister, K., Brooks, D. J. & Svenningsson, P. The noradrenergic subtype of Parkinson disease: from animal models to clinical practice. Nat. Rev. Neurol. 19, 333\u2013345 (2023).","journal-title":"Nat. Rev. Neurol."},{"key":"823_CR98","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1038\/s41591-022-01981-2","volume":"28","author":"JN Acosta","year":"2022","unstructured":"Acosta, J. N., Falcone, G. J., Rajpurkar, P. & Topol, E. J. Multimodal biomedical AI. Nat. Med 28, 1773\u20131784 (2022).","journal-title":"Nat. Med"},{"key":"823_CR99","doi-asserted-by":"publisher","unstructured":"Bucholc, M. et al. Artificial intelligence for dementia research methods optimization. Alzheimers Dement https:\/\/doi.org\/10.1002\/alz.13441 (2023).","DOI":"10.1002\/alz.13441"},{"key":"823_CR100","doi-asserted-by":"publisher","unstructured":"Winchester, L. M. et al. Artificial intelligence for biomarker discovery in Alzheimer\u2019s disease and dementia. Alzheimers Dement https:\/\/doi.org\/10.1002\/alz.13390 (2023).","DOI":"10.1002\/alz.13390"},{"key":"823_CR101","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/XEB.0000000000000055","volume":"13","author":"E Aromataris","year":"2015","unstructured":"Aromataris, E. et al. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J. Evid. Based Health. 13, 132\u2013140 (2015).","journal-title":"Int J. Evid. Based Health."},{"key":"823_CR102","unstructured":"Pollock, M. et al. Overviews of Reviews. In: Higgins J. P. T., Thomas J., Chandler J., Cumpston M., Li T., Page M. J., Welch V. A. (editors). in Cochrane Handbook for SRs of Interventions version 6.3 (updated February 2022)."},{"key":"823_CR103","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.jclinepi.2019.11.010","volume":"118","author":"MJ Page","year":"2020","unstructured":"Page, M. J. et al. Mapping of reporting guidance for systematic reviews and meta-analyses generated a comprehensive item bank for future reporting guidelines. J. Clin. Epidemiol. 118, 60\u201368 (2020).","journal-title":"J. Clin. Epidemiol."},{"key":"823_CR104","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1177\/1049732312452938","volume":"22","author":"A Cooke","year":"2012","unstructured":"Cooke, A., Smith, D. & Booth, A. Beyond PICO: the SPIDER tool for qualitative evidence synthesis. Qual. Health Res 22, 1435\u20131443 (2012).","journal-title":"Qual. Health Res"},{"key":"823_CR105","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani, M., Hammady, H., Fedorowicz, Z. & Elmagarmid, A. Rayyan-a web and mobile app for systematic reviews. Syst. Rev. 5, 210 (2016).","journal-title":"Syst. Rev."},{"key":"823_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104456","volume":"89","author":"AM Bernhardt","year":"2023","unstructured":"Bernhardt, A. M. et al. A unified classification approach rating clinical utility of protein biomarkers across neurologic diseases. eBioMedicine 89, 104456 (2023).","journal-title":"eBioMedicine"}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-024-00823-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-024-00823-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-024-00823-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T16:02:41Z","timestamp":1730563361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-024-00823-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,2]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["823"],"URL":"https:\/\/doi.org\/10.1038\/s41531-024-00823-x","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,2]]},"assertion":[{"value":"5 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare no financial or non-financial competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"211"}}